Right after the official launch of the new Apple Vision Pro mixed reality headset, Cedars-Sinai has launched a generative artificial intelligence (GenAI) app that will use
Apple has once again been prevented from selling two of its Apple Watch models in the US, in the latest phase of its patent dispute with health wearable company Masimo.
Apple has resumed the sale of some of its smartwatches in the US, after filing an emergency appeal against a decision by the Biden administration not to veto a ban on impo
Biogen has decided to close down its digital health unit, formed just two years ago, as part of a major cost-reduction drive that has already claimed thousands of jobs.
Imagine visiting your doctor’s office. Instead of swiping a co-pay card and filling out a paper form by hand, the receptionist says, “Please bring your phone closer.
Armed with new phase 3 data, Bayer has started preparing filings for elinzanetant as a treatment for vasomotor symptoms (VMS) associated with menopause, setting up a chall
The UK is welcoming a new era of clinical trial delivery, evolving beyond the traditional site-centric approach to also embrace remote, decentralised, virtual, and hybrid trials and enablin